& co.|merck|nn
withdrew|& co.|subj
vioxx|its|gen
vioxx|arthritis|nn
vioxx|drug|nn
withdrew|vioxx|obj
vioxx|market|from
market|2004|in
market|trial|after
trial|showed|vrel
showed|trial|obj
showed|increased|fc
increased|it|subj
attacks|heart|nn
increased|attacks|obj
merck|strokes|nn
income|merck|gen
income|net|nn
plunged|income|subj
plunged|29%|obj
29%|announcement|after
european medicines agency|and|punc
food and drug administration|us|nn
european medicines agency|food and drug administration|conj
announcement|announced|comp1
announced|european medicines agency|subj
announced|review|fc
review|they|subj
review|all|guest
inhibitors|cox-2|nn
review|inhibitors|obj
inhibitors|see|rel
see|inhibitor|subj
see|if|c
was|class|pred
hundreds|effect|nn
thousands|lawsuits|of
were|likely|pred
filed|merck|against
said|lawyers|subj
said|including|mod
including|lawyer|subj
lawsuits|class|nn
lawsuits|action|nn
including|lawsuits|obj
claiming|all|amod
injury|taking|from
cases|vioxx plaintiffs|gen
taking|cases|obj
claiming|strengthened|fc
strengthened|injury|obj
strengthened|when|wha
was|uncovered|pred
knew|merck|subj
risk|vioxx|gen
knew|risk|about
knew|but|punc
knew|discounted|conj
discounted|merck|subj
discounted|it|obj
